Clinical Trial

« Back to List

BRE 197

Posted by: William M. Butler, MD, FACP, Principal Investigator | Posted Date: December 31, 2012

Status: OPEN– IST
Research Hotline:
803-461-3708

Details: A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer.

This clinical trial is being offered at the following location: South Carolina Oncology Associates


Bookmark and Share